DUSP3 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.95079996601066E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.93360000000364E-06 |
Normal-vs-Stage2 |
1.608820E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.430100E-02 |
Stage1-vs-Stage2 |
7.118000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
1.413990E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
1.636650E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.09979999551868E-08 |
Normal-vs-AfricanAmerican |
2.990000E-01 |
Normal-vs-Asian |
1.605760E-01 |
Caucasian-vs-AfricanAmerican |
3.041600E-02 |
Caucasian-vs-Asian |
6.292400E-01 |
AfricanAmerican-vs-Asian |
4.208800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.21360000000059E-05 |
Normal-vs-Female |
1.61281999999652E-05 |
Male-vs-Female |
3.964200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
7.78270000000303E-05 |
Normal-vs-Extreme_Weight |
3.005900E-04 |
Normal-vs-Obese |
5.001600E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.307200E-01 |
Normal_Weight-vs-Obese |
8.517700E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
3.847000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.563620E-04 |
Normal-vs-Age(41-60Yrs) |
2.04799999999894E-05 |
Normal-vs-Age(61-80Yrs) |
1.759380E-04 |
Normal-vs-Age(81-100Yrs) |
3.191600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.817200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.692200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.248200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.466500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.465400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.505000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
5.647600E-01 |
Normal-vs-Grade 3 |
4.208000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
6.336800E-01 |
Grade 2-vs-Grade 4 |
5.647600E-01 |
Grade 3-vs-Grade 4 |
4.208000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.65879999630891E-08 |
Normal-vs-N1 |
1.620590E-01 |
N0-vs-N1 |
7.422200E-02 |
|
|